Related Experiment Video
Updated: Feb 18, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Polypill, hypertension and medication adherence: The solution strategy?
D Cimmaruta1, N Lombardi2, C Borghi3
1Department of Experimental Medicine, Section of Pharmacology "L. Donatelli", University of Campania Region "Luigi Vanvitelli", Naples, Italy.
Insights
The polypill approach significantly improves medication adherence in cardiovascular patients. This strategy may help manage hypertension and related conditions, though further real-world studies are needed.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertension is a major global health issue and a leading preventable risk factor for cardiovascular disease.
- Challenges in hypertension management include comorbidities and poor patient adherence to medications.
- The World Health Organization emphasizes improved adherence for cardiovascular disease reduction.
Purpose of the Study:
- To review evidence on the polypill approach for hypertension management.
- To assess the impact of polypills on adherence, cardiovascular risk, and safety.
Main Methods:
- Review of principal observational and clinical trial data.
- Analysis of studies focusing on adherence, cardiovascular risk reduction, and polypill safety.
Main Results:
- The polypill approach demonstrably increases adherence compared to standard care for cardiovascular patients.
- Potential for concomitant reductions in cardiovascular risk factors has been observed.
Conclusions:
- Polypill use shows promise for patients with hypertension, comorbidities, and adherence issues.
- Further real-world studies are necessary to fully establish the role of polypills in clinical practice.
Introduction:
Hypertension is an important global health challenge and a leading preventable risk factor for premature death and disability worldwide. In current cardiology practice, the main obstacles in the management of patients affected by hypertension are comorbidities and poor adherence to pharmacological treatments. The World Health Organization has recently highlighted increased adherence as a key development need for reducing cardiovascular disease.
Methods:
Principal observational and clinical trial data regarding adherence, reductions in cardiovascular risk and safety of the polypill approach are summarized and reviewed.
Conclusions:
The polypill approach has been conclusively shown to increase adherence relative to usual care in all cardiovascular patients, furthermore, concomitant risk factor reductions have also been suggested. To date, the use of polypill could represent a solution strategy in patients affected by hypertension, comorbidities and non-adherence even though further studies, especially in the real-world settings, are needed in order to better understand its role in clinical practice.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Hypertension IV: Drug Therapy and Lifestyle Modifications
Oral Drug Delivery Systems: Continuous-Release Systems
Atherosclerosis III: Management
Hypertension V: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
